In a previous study, wild type mice and mice bearing the Lewis Lung carcinoma showed hyperphosphorylation of p38 MAPK as well as inhibition of AKT signaling and activation of the myostatin pathway in response to different chemotherapeutics [11, 50]. The gene discussed is MSTN; the disease is Carcinoma, Lewis Lung.